Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice
Nicole R. Bonetti(University Hospital Zurich), Jürg H. Beer(University of Zurich), Seyed Soheil Saeedi Saravi(University of Zurich), Brian C. Cooley, Riitta Lassila(University of Helsinki), Giovanni G. Camici(University of Zurich), Luca Liberale(Azienda Ospedaliera di Perugia), Lisa Pasterk(University of Zurich), S Gobbato(University of Zurich), Thomas F. Lüscher(University of Zurich), Annukka Jouppila(University of Helsinki)
Cited by 6
Related Papers
The Assessment of Endothelial Function
|Circulation|2012|1.1k
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
|Journal of Clinical Investigation|1990|1.1k
Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans
|European Heart Journal|2019|952
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
|European Heart Journal|2016|676
Impact of Oxidative Stress on the Heart and Vasculature
|Journal of the American College of Cardiology|2017|603